£118.20
This MT-1 + Ipamorelin peptide blend contains 1.2 mg of Melanotan I (MT-1) and 0.9 mg of Ipamorelin, providing a dual-pathway research tool for controlled studies involving melanocortin signaling and GH-axis activity. MT-1 is a linear analogue of α-MSH used to explore melanocortin receptor behavior, pigmentation pathways, and neuropeptide-mediated communication under laboratory conditions. Ipamorelin is a selective GHSR agonist studied for its ability to stimulate targeted pituitary GH release without non-specific hormonal effects.
Researchers value this pairing because it enables the examination of two distinct signaling systems in a single experimental model. The MT-1 + Ipamorelin peptide blend supports mechanistic studies into how neuropeptide pathways and controlled GH activation may interact or operate independently in vitro or ex vivo.
Laboratory teams typically select this blend for:
Mapping melanocortin receptor responses in controlled systems
Studying selective growth-hormone stimulation and pituitary signaling
Exploring peptide-driven pathway specificity and communication
Comparing dual-peptide exposure with single-compound experiments
Because both peptides provide predictable activity profiles in defined experimental conditions, the blend supports reproducible mechanistic research and accurate dose-response assessment. The controlled formulation assists in generating clean data output for metabolic, endocrine, and neurochemical studies.
This MT-1 + Ipamorelin peptide blend is supplied as a high-purity laboratory reagent intended only for qualified scientific professionals. It is not approved for clinical, therapeutic, diagnostic, or veterinary use. All handling must follow institutional laboratory safety standards and regulatory compliance for investigational compounds.
For research use only. Not for human consumption.
Discount Applied Successfully!
Your savings have been added to the cart.
